The global HBsAg testing market was valued at USD 1.30 billion in 2023 and is expected to expand from USD 1.37 billion in 2024 to reach USD 2.16 billion by 2032, registering a compound annual growth rate (CAGR) of 5.8% during the forecast period.
Request a Free Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hbsag-testing-market-110984
The Hepatitis B surface antigen (HBsAg) testing market plays a crucial role in the early detection and management of Hepatitis B Virus (HBV) infections. With the increasing prevalence of HBV worldwide, the demand for accurate and efficient HBsAg testing has surged. This article delves into the current market landscape, highlighting key players, recent industry developments, market drivers and restraints, segmentation, regional insights, and future prospects.
The HBsAg testing market is characterized by the presence of several prominent companies that contribute significantly to its growth. Notable players include:
In October 2024, Siemens Healthineers AG entered into a 12-year value partnership with University Hospital Nantes to advance diagnostic and interventional imaging. This collaboration aims to enhance diagnostic capabilities and improve patient outcomes through innovative imaging solutions.